Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers.

Abstract

Alzheimer's disease is an age-related dementia and its incidence is rising in developed countries as the population ages. Amyloid plaques and tau-rich neurofibrillary tangles are pathologic hallmarks of the disease. Treatment is symptomatic, consisting of compounds that block enzymatic acetylcholine degradation (acetylcholinesterase inhibitors). Cognitive… (More)

Topics

Cite this paper

@article{Silverberg2004NovelVS, title={Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers.}, author={Gerald Silverberg and Martha R. Mayo and Thomas Saul and J B V Carvalho and Dawn McGuire}, journal={Expert review of neurotherapeutics}, year={2004}, volume={4 1}, pages={97-107} }